David Croteau
Overview
Explore the profile of David Croteau including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
31
Citations
1095
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kim T, Brinker A, Croteau D, Lee P, Baldassari L, Pimentel-Maldonado D, et al.
Mult Scler
. 2025 Feb;
:13524585251316518.
PMID: 39931911
Background: Although gastrointestinal (GI) adverse reactions (ARs) were commonly observed in registrational clinical trials of fumarate acid ester (FAE) drugs for the treatment of multiple sclerosis, serious GI reactions were...
2.
Croteau D, Kim T, Chan V, Stevens J, Pimentel Maldonado D, Baldassari L, et al.
Mult Scler Relat Disord
. 2024 Nov;
92:106163.
PMID: 39541823
Background: Risk factors for progressive multifocal leukoencephalopathy (PML) associated with sphingosine-1-phosphate receptor (S1PR) modulators are not as well-characterized as for natalizumab. We characterized S1PR modulator-associated PML cases and risk factors...
3.
Kim T, Brinker A, Croteau D, Lee P, Baldassari L, Stevens J, et al.
Mult Scler
. 2023 Sep;
29(10):1275-1281.
PMID: 37706451
Background: An association between certain immunomodulatory therapies (rituximab, ipilimumab, and other immune checkpoint inhibitors) and inflammatory (non-ischemic and non-infectious) colitis in oncologic and non-oncologic patient populations is well documented in...
4.
Mohamoud M, Chen Q, Croteau D, Cheng C, Burkhart K, Volpe D, et al.
J Clin Psychopharmacol
. 2022 Apr;
42(3):238-246.
PMID: 35489029
Purpose/background: Acute hyperkinetic movement disorders have been reported with the concomitant use of attention-deficit/hyperactivity disorder (ADHD) stimulants and antipsychotics in children and adolescents. We analyzed postmarketing reports of suspected acute...
5.
Croteau D, Pinnow E, Wu E, Munoz M, Bulatao I, Dal Pan G
Drug Saf
. 2022 Feb;
45(2):169-180.
PMID: 35113347
Introduction: New safety issues concerning US FDA-approved drugs are commonly communicated through safety-related labeling changes. Therefore, to optimize and refine postmarket safety surveillance strategies, it is important to comprehensively characterize...
6.
Saely S, Croteau D, Jawidzik L, Brinker A, Kortepeter C
Headache
. 2021 Jan;
61(1):202-208.
PMID: 33423274
Objective: To identify and analyze postmarketing case reports of elevated blood pressure (BP) associated with erenumab use. Methods: A retrospective analysis of postmarketing (spontaneous) case reports of erenumab-associated elevated BP...
7.
Kim T, Croteau D, Brinker A, Jones D, Lee P, Kortepeter C
Mult Scler
. 2020 Dec;
27(8):1301-1305.
PMID: 33300850
Background: Only progressive multifocal leukoencephalopathy (PML) is currently described in the dimethyl fumarate (DMF) prescribing information. Objectives: To describe opportunistic infections (OIs), other than PML, reported in association with DMF....
8.
Croteau D, Tobenkin A, Brinker A, Kortepeter C
Mult Scler
. 2020 Jul;
27(6):903-912.
PMID: 32662718
Background: Tumefactive multiple sclerosis (TMS) is a rare multiple sclerosis (MS) form that usually manifests as the initial presentation or in the early stages of MS. Objective: The aim of...
9.
Harbourt K, Nevo O, Zhang R, Chan V, Croteau D
Pharmacoepidemiol Drug Saf
. 2020 Apr;
29(6):684-691.
PMID: 32323442
Purpose: To identify and analyze postmarketing cases of complex sleep behaviors (CSBs) resulting in serious injuries, including death, associated with eszopiclone, zaleplon, or zolpidem (Z-drugs). Methods: Retrospective analysis of the...
10.
Anderson A, Croteau D, Ellis R, Rosario D, Potter M, Guillemin G, et al.
J Neuroimmunol
. 2018 Apr;
319:13-18.
PMID: 29685284
There is mounting evidence that prospective memory (PM) is impaired during HIV infection despite treatment. In this prospective study, 66 adults (43 HIV+ and 23 HIV negative) underwent PM assessment...